Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms

Clinical trial NCT01520220 · COMPLETED

Trial details

NCT number: NCT01520220
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Myeloproliferative Neoplasms of Polycythemia Vera Essential Thrombocythemia Myelofibrosis

Start date: 2012-06-11
Primary completion: 2015-06-26
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.